A prospective 8 week trial of nasal interfaces vs. a novel oral interface (Oracle™) for treatment of obstructive sleep apnea hypopnea syndrome A prospective 8 week trial of nasal interfaces vs. a novel oral interface (Oracle™) for treatment of obstructive sleep apnea hypopnea syndrome Download Treatment of nocturnal eating syndrome and sleep-related eating disorder with topiramate Accuracy of sleep perceptions among insomnia sufferers and normal sleepers
